Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last €57.40 EUR
Change Today -0.18 / -0.31%
Volume 359.0
SAVE On Other Exchanges
EN Paris
As of 11:35 AM 11/27/15 All times are local (Market data is delayed by at least 15 minutes).

savencia sa (SAVE) Snapshot

Previous Close
Day High
Day Low
52 Week High
05/11/15 - €64.85
52 Week Low
01/15/15 - €49.50
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for SAVENCIA SA (SAVE)

Related News

No related news articles were found.

savencia sa (SAVE) Related Businessweek News

No Related Businessweek News Found

savencia sa (SAVE) Details

Savencia SA produces and distributes cheese and other dairy specialties, and dairy ingredients in France, other European countries, and internationally. The company provides cream cheese, branded cheese, processed cheeses, fresh cheeses, pressed cheeses, milk and dairy desserts, cheese sauces, and fresh and UHT cream ingredients for cooking and whipping. It also offers butters and cream for the retail markets and food service professionals, as well as dairy ingredients for the agro-food, health, and nutrition industries; and milk replacers for calves, lambs, kids, foals, and piglets. The company was formerly known as Bongrain SA and changed its name to Savencia SA in April 2015. The company is based in Viroflay, France. Savencia SA is a subsidiary of Soparind SCA.

19,246 Employees
Last Reported Date: 04/27/15

savencia sa (SAVE) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

savencia sa (SAVE) Key Developments

Savencia Announces Consolidated Sales Results for the Period Ended September 2015

Savencia announced consolidated sales results for the period ended September 2015. For the period, the company reported net sales of EUR 3,261 million against EUR 3,353 million a year ago.

Bongrain French will Change its Name to Savencia SA

Effective September 11, 2015, Bongrain French will change its name to Savencia SA.

Savencia Announces Earnings Results for the First Half of 2015

Savencia announced earnings results for the first half of 2015. Net sales were €2,179 million compared to €2,232 million a year ago. Operating profit was €65 million compared to €52 million a year ago. Group share of net income was €35 million compared to €18 million a year ago. Net debt was €419 million compared to €599 a year ago.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
SAVE:FP €57.40 EUR -0.18

SAVE Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Danone SA €65.02 EUR -0.21
Fleury Michon SA €65.55 EUR -0.45
Mondelez International Inc $44.42 USD +0.49
Nestle SA SFr.76.40 CHF +0.40
View Industry Companies

Industry Analysis


Industry Average

Valuation SAVE Industry Range
Price/Earnings 15.1x
Price/Sales 0.2x
Price/Book 0.7x
Price/Cash Flow 13.6x
TEV/Sales NM Not Meaningful

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact SAVENCIA SA, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at